These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38847538)

  • 41. Detection and characterization of carbapenem resistant Gram-negative bacilli isolates recovered from hospitalized patients at Soba University Hospital, Sudan.
    Elbadawi HS; Elhag KM; Mahgoub E; Altayb HN; Ntoumi F; Elton L; McHugh TD; Tembo J; Ippolito G; Osman AY; Zumla A; Hamid MMA
    BMC Microbiol; 2021 May; 21(1):136. PubMed ID: 33947325
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microbial infection pattern, pathogenic features and resistance mechanism of carbapenem-resistant Gram negative bacilli during long-term hospitalization.
    Wen S; Feng D; Lu Z; Liu J; Peters BM; Tang H; Su D; Lin YP; Yang L; Xu Z; Shirtliff ME; Chen D
    Microb Pathog; 2018 Apr; 117():356-360. PubMed ID: 29452198
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of Resistant Gram-Negative Bacilli in Bloodstream Infection in Febrile Neutropenia Patients Undergoing Hematopoietic Stem Cell Transplantation: A Single Center Retrospective Cohort Study.
    Wang L; Wang Y; Fan X; Tang W; Hu J
    Medicine (Baltimore); 2015 Nov; 94(45):e1931. PubMed ID: 26559260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acquisition of carbapenem-resistant Gram-negative bacilli in intensive care unit: predictors and molecular epidemiology.
    Marchenay P; Blasco G; Navellou JC; Leroy J; Cholley P; Talon D; Bertrand X; Gbaguidi-Haore H
    Med Mal Infect; 2015; 45(1-2):34-40. PubMed ID: 25640914
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia.
    Clerici D; Oltolini C; Greco R; Ripa M; Giglio F; Mastaglio S; Lorentino F; Pavesi F; Farina F; Liberatore C; Castiglion B; Tassan Din C; Bernardi M; Corti C; Peccatori J; Scarpellini P; Ciceri F; Castagna A
    Int J Antimicrob Agents; 2021 Jun; 57(6):106335. PubMed ID: 33838223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic characterisation of carbapenem-resistant Gram-negative bacteria isolated from the University Hospital Mohamed Boudiaf in Ouargla, southern Algeria.
    Yagoubat M; Ould El-Hadj-Khelil A; Malki A; Bakour S; Touati A; Rolain JM
    J Glob Antimicrob Resist; 2017 Mar; 8():55-59. PubMed ID: 28007519
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of diverse carbapenem and multidrug resistance genes and high-risk strain types among carbapenem non-susceptible clinical isolates of target gram-negative bacteria in Kenya.
    Musila L; Kyany'a C; Maybank R; Stam J; Oundo V; Sang W
    PLoS One; 2021; 16(2):e0246937. PubMed ID: 33617559
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Novel Risk Predictive Scoring Model for Predicting Subsequent Infection After Carbapenem-Resistant Gram-Negative Bacteria Colonization in Hematological Malignancy Patients.
    Wu Q; Qian C; Yin H; Liu F; Wu Y; Li W; Xia L; Ma L; Hong M
    Front Oncol; 2022; 12():897479. PubMed ID: 35651791
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Imipenem-resistant Gram-negative bacterial isolates carried by persons upon medical examination in Korea.
    Kim SY; Shin SY; Rhee JY; Ko KS
    J Microbiol; 2017 Aug; 55(8):612-618. PubMed ID: 28721477
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bacteremia in critical care units at Bugando Medical Centre, Mwanza, Tanzania: the role of colonization and contaminated cots and mothers' hands in cross-transmission of multidrug resistant Gram-negative bacteria.
    Silago V; Kovacs D; Msanga DR; Seni J; Matthews L; Oravcová K; Zadoks RN; Lupindu AM; Hoza AS; Mshana SE
    Antimicrob Resist Infect Control; 2020 May; 9(1):58. PubMed ID: 32375857
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimating the association between antibiotic exposure and colonization with extended-spectrum β-lactamase-producing Gram-negative bacteria using machine learning methods: a multicentre, prospective cohort study.
    Tacconelli E; Górska A; De Angelis G; Lammens C; Restuccia G; Schrenzel J; Huson DH; Carević B; Preoţescu L; Carmeli Y; Kazma M; Spanu T; Carrara E; Malhotra-Kumar S; Gladstone BP
    Clin Microbiol Infect; 2020 Jan; 26(1):87-94. PubMed ID: 31128285
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A method to quantify viable carbapenem resistant gram-negative bacteria in treated and untreated wastewater.
    Reinke RA; Quach-Cu J; Allison N; Lynch B; Crisostomo C; Padilla M
    J Microbiol Methods; 2020 Dec; 179():106070. PubMed ID: 33017624
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Colonization With Antimicrobial-Resistant Gram-Negative Bacilli at Neonatal Intensive Care Unit Discharge.
    Clock SA; Ferng YH; Tabibi S; Alba L; Patel SJ; Jia H; DeLaMora P; Perlman JM; Paul DA; Zaoutis T; Larson EL; Saiman L
    J Pediatric Infect Dis Soc; 2017 Sep; 6(3):219-226. PubMed ID: 27021036
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibiotics with activity against intestinal anaerobes and the hazard of acquired colonization with ceftriaxone-resistant Gram-negative pathogens in ICU patients: a propensity score-based analysis.
    Boutrot M; Azougagh K; Guinard J; Boulain T; Barbier F
    J Antimicrob Chemother; 2019 Oct; 74(10):3095-3103. PubMed ID: 31289826
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of an Active Surveillance Program and Enhanced Infection Control Measures on Carbapenem-Resistant Gram-Negative Bacterial Carriage and Infections in Pediatric Intensive Care.
    Karampatakis T; Tsergouli K; Iosifidis E; Antachopoulos C; Volakli E; Karyoti A; Sdougka M; Tsakris A; Roilides E
    Microb Drug Resist; 2019 Nov; 25(9):1347-1356. PubMed ID: 31364923
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy.
    Lee JY; Kang CI; Ko JH; Lee WJ; Seok HR; Park GE; Cho SY; Ha YE; Chung DR; Lee NY; Peck KR; Song JH
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6673-6678. PubMed ID: 27572416
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa.
    Hu Y; Qing Y; Chen J; Liu C; Lu J; Wang Q; Zhen S; Zhou H; Huang L; Zhang R
    Microbiol Spectr; 2021 Dec; 9(3):e0134421. PubMed ID: 34817230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Impact of antimicrobial stewardship program on antimicrobial usage and detection rate of multidrug-resistant gram-negative bacteria].
    Xu YL; Hu LM; Xie ZZ; Dong YW; Dong L
    Zhonghua Er Ke Za Zhi; 2019 Jul; 57(7):553-558. PubMed ID: 31269557
    [No Abstract]   [Full Text] [Related]  

  • 59. Presence, distribution and molecular epidemiology of multi-drug-resistant Gram-negative bacilli from medical personnel of intensive care units in Tianjin, China, 2007-2015.
    Liu H; Fei CN; Zhang Y; Liu GW; Liu J; Dong J
    J Hosp Infect; 2017 Jun; 96(2):101-110. PubMed ID: 28268024
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment and Outcome of Carbapenem-Resistant Gram-Negative Bacilli Blood-Stream Infections in a Tertiary Care Hospital.
    Shah PG; Shah SR
    J Assoc Physicians India; 2015 Jul; 63(7):14-8. PubMed ID: 26731822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.